CINCINNATI, Feb. 6, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or (“Tauriga” or “the Company”), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today announced the execution of a multi faceted service agreement (“the agreement”) with the University of Cincinnati Research Institute (“UCRI”) to facilitate the commercialization of the Company’s proprietary bacterial robot (“BactoBot™") technology platform for treatment and remediation of wastewater. Through the signing of this agreement with UCRI, the company gains access to a work class laboratory in preparation for its anticipated two commercial pilot tests. In addition the Company plans to develop new products, such as the PCB remediating Nuclear BactoBot™, and the rapid prototyping expertise of the UCRI scientists will be of great value to the Company.
Help employers find you! Check out all the jobs and post your resume.
